Edwards Lifesciences EW Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Edwards Lifesciences’s reported figures.
Based on the most recent quarter.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's current ratio?
- Edwards Lifesciences (EW) reported current ratio of 4.4× in Q1 2026.
- How has Edwards Lifesciences's current ratio changed year-over-year?
- Edwards Lifesciences's current ratio decreased by 0.8% year-over-year, from 4.5× to 4.4×.
- What is the long-term trend for Edwards Lifesciences's current ratio?
- Over 4 years (2021 to 2025), Edwards Lifesciences's current ratio has grown at a 4.2% compound annual growth rate (CAGR), from 14.3× to 16.9×.
- What does current ratio mean?
- Whether the company has enough short-term assets to cover its short-term bills.
- How do you interpret current ratio?
- Above 1.0 means short-term assets cover short-term liabilities. Very high values can signal idle cash or bloated inventory/receivables rather than strength — there's a healthy middle, not 'more is better'.
- How does current ratio compare across companies?
- Comparable within an industry. Working-capital-light businesses can operate safely below 1.0 by collecting before they pay.